- Home
- HKIT vs COEP Comparison
HKIT vs COEP Comparison
Compare HKIT & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- COEP
- Stock Information
- Founded
- HKIT 1996
- COEP 2017
- Country
- HKIT China
- COEP United States
- Employees
- HKIT N/A
- COEP N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HKIT Technology
- COEP Health Care
- Exchange
- HKIT Nasdaq
- COEP Nasdaq
- Market Cap
- HKIT 35.7M
- COEP 30.5M
- IPO Year
- HKIT 2023
- COEP N/A
- Fundamental
- Price
- HKIT $1.30
- COEP $9.38
- Analyst Decision
- HKIT
- COEP
- Analyst Count
- HKIT 0
- COEP 0
- Target Price
- HKIT N/A
- COEP N/A
- AVG Volume (30 Days)
- HKIT 14.6K
- COEP 47.7K
- Earning Date
- HKIT 04-08-2025
- COEP 05-09-2025
- Dividend Yield
- HKIT N/A
- COEP N/A
- EPS Growth
- HKIT N/A
- COEP N/A
- EPS
- HKIT 0.04
- COEP N/A
- Revenue
- HKIT $3,449,206.00
- COEP N/A
- Revenue This Year
- HKIT N/A
- COEP N/A
- Revenue Next Year
- HKIT N/A
- COEP N/A
- P/E Ratio
- HKIT $34.28
- COEP N/A
- Revenue Growth
- HKIT N/A
- COEP N/A
- 52 Week Low
- HKIT $1.00
- COEP $2.31
- 52 Week High
- HKIT $2.18
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- HKIT 52.70
- COEP 44.44
- Support Level
- HKIT $1.23
- COEP $9.24
- Resistance Level
- HKIT $1.39
- COEP $9.75
- Average True Range (ATR)
- HKIT 0.05
- COEP 0.94
- MACD
- HKIT 0.01
- COEP -0.09
- Stochastic Oscillator
- HKIT 52.00
- COEP 39.39
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.